Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Michels

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Disability and Rehabilitation|May 13, 2020
Medical Therapeutic Yoga for multiple sclerosis: examining self-efficacy for physical activity, motivation for physical activity, and quality of life outcomesKimberly S Fasczewski, LaVerene M Garner, Lauren A Clark, et al.
The British Journal of Ophthalmology|February 28, 2008
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical studyG Weigert, S Michels, S Sacu, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2006
[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration]W Geitzenauer, S Michels, F Prager, et al.
Orbit (Amsterdam, Netherlands)|December 1, 2021
Orbital cellulitis and cavernous sinus thrombosis with contralateral sinus disease in a COVID-19 positive adolescent patientAmelia S Lawrence, David G Stoddard, Craig N Czyz, et al.
The British Journal of Ophthalmology|January 24, 2008
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective studyK Kriechbaum, S Michels, F Prager, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyesUrsula Schlötzer-Schrehardt, Arne Viestenz, Gottfried O H Naumann, et al.
The British Journal of Ophthalmology|December 17, 2008
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trialF Prager, S Michels, K Kriechbaum, et al.
Eye (London, England)|January 27, 2009
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term resultsS Sacu, S Michels, F Prager, et al.
The British Journal of Ophthalmology|July 1, 2008
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised studyS Sacu, A Varga, S Michels, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 22, 2010
Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad respondersM Menghini, M M Kurz-Levin, C Amstutz, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Disability and Rehabilitation|May 13, 2020
Medical Therapeutic Yoga for multiple sclerosis: examining self-efficacy for physical activity, motivation for physical activity, and quality of life outcomesKimberly S Fasczewski, LaVerene M Garner, Lauren A Clark, et al.
The British Journal of Ophthalmology|February 28, 2008
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical studyG Weigert, S Michels, S Sacu, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 26, 2006
[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration]W Geitzenauer, S Michels, F Prager, et al.
Orbit (Amsterdam, Netherlands)|December 1, 2021
Orbital cellulitis and cavernous sinus thrombosis with contralateral sinus disease in a COVID-19 positive adolescent patientAmelia S Lawrence, David G Stoddard, Craig N Czyz, et al.
The British Journal of Ophthalmology|January 24, 2008
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective studyK Kriechbaum, S Michels, F Prager, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyesUrsula Schlötzer-Schrehardt, Arne Viestenz, Gottfried O H Naumann, et al.
The British Journal of Ophthalmology|December 17, 2008
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trialF Prager, S Michels, K Kriechbaum, et al.
Eye (London, England)|January 27, 2009
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term resultsS Sacu, S Michels, F Prager, et al.
The British Journal of Ophthalmology|July 1, 2008
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised studyS Sacu, A Varga, S Michels, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 22, 2010
Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad respondersM Menghini, M M Kurz-Levin, C Amstutz, et al.
Pageof 8